BRPI0817444A2 - Prímeres de poliunucleotídeo - Google Patents

Prímeres de poliunucleotídeo

Info

Publication number
BRPI0817444A2
BRPI0817444A2 BRPI0817444-0A BRPI0817444A BRPI0817444A2 BR PI0817444 A2 BRPI0817444 A2 BR PI0817444A2 BR PI0817444 A BRPI0817444 A BR PI0817444A BR PI0817444 A2 BRPI0817444 A2 BR PI0817444A2
Authority
BR
Brazil
Prior art keywords
polyunucleotide
primers
polyunucleotide primers
Prior art date
Application number
BRPI0817444-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Ruth Board
Jennifer Ferguson
Paul Francis Ravetto
Nicola Jo Thelwell
David Whitcombe
Original Assignee
Dxs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dxs Ltd filed Critical Dxs Ltd
Publication of BRPI0817444A2 publication Critical patent/BRPI0817444A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0817444-0A 2007-09-28 2008-09-29 Prímeres de poliunucleotídeo BRPI0817444A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0719034A GB2453173A (en) 2007-09-28 2007-09-28 Polynucleotide primers
PCT/GB2008/003306 WO2009040557A2 (en) 2007-09-28 2008-09-29 Polynucleotide primers for detecting pik3ca mutations

Publications (1)

Publication Number Publication Date
BRPI0817444A2 true BRPI0817444A2 (pt) 2015-06-16

Family

ID=38701889

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817444-0A BRPI0817444A2 (pt) 2007-09-28 2008-09-29 Prímeres de poliunucleotídeo

Country Status (13)

Country Link
US (4) US8901285B2 (cg-RX-API-DMAC7.html)
EP (7) EP2505673B1 (cg-RX-API-DMAC7.html)
JP (1) JP5719593B2 (cg-RX-API-DMAC7.html)
KR (4) KR101543214B1 (cg-RX-API-DMAC7.html)
CN (4) CN103695558B (cg-RX-API-DMAC7.html)
AU (1) AU2008303400B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0817444A2 (cg-RX-API-DMAC7.html)
CA (2) CA2700710C (cg-RX-API-DMAC7.html)
ES (6) ES2622885T3 (cg-RX-API-DMAC7.html)
GB (1) GB2453173A (cg-RX-API-DMAC7.html)
MX (1) MX2010003486A (cg-RX-API-DMAC7.html)
RU (1) RU2491289C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009040557A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190171B2 (en) 2007-09-28 2019-01-29 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2786696C (en) * 2010-01-12 2021-05-25 Jill Detmer Oligonucleotides and methods for detecting pik3ca mutations
JP2013081450A (ja) * 2011-09-27 2013-05-09 Arkray Inc 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット
CN102453765B (zh) * 2011-11-03 2013-07-24 厦门艾德生物医药科技有限公司 Pik3ca基因驱动突变的检测探针、引物及试剂盒
NZ628596A (en) 2012-03-29 2015-10-30 Novartis Ag Pharmaceutical diagnostics for treatment of cancer in subjects having pi3k mutation
CN102816839A (zh) * 2012-07-06 2012-12-12 杭州艾迪康医学检验中心有限公司 用于检测结直肠癌pik3ca基因热点突变位点的试剂盒
EP2711432A1 (en) * 2012-09-21 2014-03-26 Genomica S.A.U. Method for detection of BRAF and PI3K mutations
WO2014140061A2 (en) * 2013-03-13 2014-09-18 Roche Diagnostics Gmbh Methods and compositions for detecting mutations in the human pi3kca (pik3ca) gene
CN103773837A (zh) * 2013-06-25 2014-05-07 宁波有成生物医药科技有限公司 一种pik3ca基因突变荧光定量pcr检测试剂盒及检测方法
RU2549682C1 (ru) * 2013-10-21 2015-04-27 Общество с ограниченной ответственностью "БИОЧИП-ИМБ" Способ анализа соматических мутаций в гене pi3k с использованием lna-блокирующей мультиплексной пцр и последующей гибридизацией с олигонуклеотидным биологическим микрочипом (биочипом)
WO2015161274A1 (en) * 2014-04-18 2015-10-22 Blueprint Medicines Corporation Pik3ca fusions
CN105274188A (zh) * 2014-05-29 2016-01-27 北京雅康博生物科技有限公司 Pik3ca基因突变检测试剂盒
WO2016020710A1 (en) * 2014-08-07 2016-02-11 Pharmassist Ltd Method of determining pik3ca mutational status in a sample
US12391985B2 (en) 2014-08-07 2025-08-19 Pharmassist Ltd Method of determining PIK3CA mutational status in a sample
US10276072B2 (en) * 2014-09-03 2019-04-30 Washme Properties, Llc Illuminated sign
CN105441533B (zh) * 2014-11-29 2019-07-05 上海赛安生物医药科技有限公司 Pik3ca基因突变检测体系及其试剂盒
CN104531875A (zh) * 2014-12-30 2015-04-22 宁波有成生物医药科技有限公司 一种MyD88基因突变荧光定量PCR检测试剂盒及检测方法
KR20250078789A (ko) 2023-11-24 2025-06-04 주식회사 캐니캐티케어 반려동물의 pik3ca 유전자 돌연변이성 종양 검출용 조성물 및 이를 이용한 반려동물의 pik3ca 유전자 돌연변이성 종양 진단방법
WO2025110738A1 (ko) * 2023-11-24 2025-05-30 주식회사 캐니캐티케어 반려동물의 pik3ca 유전자 돌연변이성 종양 검출용 조성물 및 이를 이용한 반려동물의 pik3ca 유전자 돌연변이성 종양 진단방법

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US6274327B1 (en) 1992-04-13 2001-08-14 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US5846824A (en) 1994-02-07 1998-12-08 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
US20030225013A1 (en) * 2002-05-31 2003-12-04 Isis Pharmaceuticals Inc. Antisense modulation of phosphoinositide-3-kinase, regulatory subunit 4, p150 expression
US5847972A (en) 1993-09-24 1998-12-08 Eick; Stephen Gregory Method and apparatus for graphically analzying a log-file
US6043062A (en) 1995-02-17 2000-03-28 The Regents Of The University Of California Constitutively active phosphatidylinositol 3-kinase and uses thereof
US5948664A (en) 1996-02-29 1999-09-07 The Regents Of The University Of California PI 3-kinase polypeptides
CA2239463A1 (en) * 1996-11-01 1998-05-14 Onyx Pharmaceuticals, Inc. Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
US6277563B1 (en) 1997-01-16 2001-08-21 The Regents Of The University Of California Genetic alterations associated with cancer
US5955277A (en) 1997-05-05 1999-09-21 Novo Nordisk A/S Mutant cDNA encoding the p85α subunit of phosphatidylinositol 3-kinase
US5994076A (en) * 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US8101349B2 (en) 1997-12-23 2012-01-24 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells and their methods of use II
US6537751B1 (en) 1998-04-21 2003-03-25 Genset S.A. Biallelic markers for use in constructing a high density disequilibrium map of the human genome
JP2002534055A (ja) 1998-05-14 2002-10-15 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物ｖ
GB9812768D0 (en) 1998-06-13 1998-08-12 Zeneca Ltd Methods
US6274237B1 (en) * 1999-05-21 2001-08-14 Chisso Corporation Potentially crimpable composite fiber and a non-woven fabric using the same
AU781151B2 (en) * 1999-10-26 2005-05-12 Immusol Incorporated Ribozyme therapy for the treatment of proliferative skin and eye diseases
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
AU2001294842A1 (en) 2000-09-28 2002-04-08 Atairgin Technologies, Inc. A method of determining tumor characteristics by determining abnormal copy number or expression level of lipid-associated genes
USH2191H1 (en) * 2000-10-24 2007-06-05 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
CN1358850A (zh) * 2000-12-13 2002-07-17 上海博德基因开发有限公司 一种新的多肽——人磷脂酰肌醇3(PtdIns 3)－激酶17.6和编码这种多肽的多核苷酸
CA2372542A1 (en) 2001-02-20 2002-08-20 Pfizer Products Inc. Transgenic animals containing a dominant negative mutant form of the p85 subunit of pi-3 kinase
US20030162174A1 (en) * 2001-06-11 2003-08-28 Sutherland John W. Detecting nucleic acid deletion sequences
WO2003025175A2 (fr) * 2001-09-17 2003-03-27 Molecular Engines Laboratories Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
US20030182669A1 (en) 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
US7955800B2 (en) 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
CA2491023A1 (en) * 2002-07-19 2004-01-29 Althea Technologies, Inc. Strategies for gene expression analysis
US7217807B2 (en) * 2002-11-26 2007-05-15 Rosetta Genomics Ltd Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
RU2240350C1 (ru) * 2003-03-11 2004-11-20 НИИ онкологии им. проф. Н.Н.Петрова Минздрава РФ Способ идентификации генных мутаций и полиморфизмов
US20070054278A1 (en) 2003-11-18 2007-03-08 Applera Corporation Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
PT3296407T (pt) 2004-03-02 2019-08-23 Univ Johns Hopkins Mutações do gene pik3ca em cancros humanos
US20050287559A1 (en) * 2004-05-07 2005-12-29 Applera Corporation Genetic polymorphisms associated with vascular, methods of detection and uses thereof
US20050287570A1 (en) * 2004-05-26 2005-12-29 Wyeth Probe arrays for expression profiling of rat genes
US7981605B2 (en) * 2005-02-24 2011-07-19 Amgen Inc. Epidermal growth factor receptor mutations
WO2006094149A2 (en) 2005-03-01 2006-09-08 Exact Sciences Corporation Methods and compositions for detecting adenoma
CN103889006B (zh) * 2005-03-14 2017-09-15 皇家飞利浦电子股份有限公司 区分服务的无线网络中的QoS测量和监视
GB2424886A (en) * 2005-04-04 2006-10-11 Dxs Ltd Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
DK1948816T3 (da) * 2005-10-24 2012-04-02 Univ Johns Hopkins Forbedrede fremgangsmåder til beaming
JP4477575B2 (ja) * 2005-12-14 2010-06-09 株式会社日立製作所 大腸がんの検査に使用する遺伝子セット
AU2007225238A1 (en) * 2006-03-10 2007-09-20 Wyeth Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae
GB2453173A (en) 2007-09-28 2009-04-01 Dxs Ltd Polynucleotide primers
TW200927176A (en) 2007-12-03 2009-07-01 Santaris Pharma As RNA antagonist compounds for the modulation of PIK3CA expression

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190171B2 (en) 2007-09-28 2019-01-29 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations
US10196692B2 (en) 2007-09-28 2019-02-05 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations

Also Published As

Publication number Publication date
ES2532141T3 (es) 2015-03-24
KR20100101070A (ko) 2010-09-16
JP2010539920A (ja) 2010-12-24
CA3010064A1 (en) 2009-04-02
EP2239341A1 (en) 2010-10-13
US20140141425A1 (en) 2014-05-22
CA2700710C (en) 2018-08-21
CN103952466A (zh) 2014-07-30
CN103695558B (zh) 2016-01-20
US20160040255A1 (en) 2016-02-11
ES2622885T3 (es) 2017-07-07
JP5719593B2 (ja) 2015-05-20
GB0719034D0 (en) 2007-11-07
EP2236627A8 (en) 2010-12-01
EP2205760B1 (en) 2012-06-27
CN102119222A (zh) 2011-07-06
EP2505671A1 (en) 2012-10-03
KR20150038660A (ko) 2015-04-08
US10196692B2 (en) 2019-02-05
KR20150038661A (ko) 2015-04-08
EP2508624A1 (en) 2012-10-10
KR101543216B1 (ko) 2015-08-07
WO2009040557A2 (en) 2009-04-02
CA2700710A1 (en) 2009-04-02
RU2491289C2 (ru) 2013-08-27
CN103834724B (zh) 2016-05-25
CN103695558A (zh) 2014-04-02
KR101543214B1 (ko) 2015-08-07
WO2009040557A3 (en) 2009-05-14
CN103952466B (zh) 2016-07-06
AU2008303400B2 (en) 2013-09-26
EP2236627A1 (en) 2010-10-06
US10190171B2 (en) 2019-01-29
EP2239341A8 (en) 2010-12-01
EP2205760A2 (en) 2010-07-14
US9863003B2 (en) 2018-01-09
EP2239341B1 (en) 2015-01-14
EP2505671B1 (en) 2017-02-01
EP2505673B1 (en) 2017-02-01
ES2532225T3 (es) 2015-03-25
GB2453173A (en) 2009-04-01
RU2010116772A (ru) 2011-11-10
KR101543215B1 (ko) 2015-08-07
EP2505672B1 (en) 2015-01-14
CN102119222B (zh) 2015-11-25
KR101548758B1 (ko) 2015-09-01
EP2505673A1 (en) 2012-10-03
EP2508624B1 (en) 2015-01-14
CN103834724A (zh) 2014-06-04
ES2620289T3 (es) 2017-06-28
US8901285B2 (en) 2014-12-02
ES2531994T3 (es) 2015-03-23
EP2236627B1 (en) 2015-01-14
KR20150038659A (ko) 2015-04-08
US20110027779A1 (en) 2011-02-03
MX2010003486A (es) 2010-08-09
US20160032408A1 (en) 2016-02-04
AU2008303400A1 (en) 2009-04-02
EP2505672A1 (en) 2012-10-03
ES2531055T3 (es) 2015-03-10

Similar Documents

Publication Publication Date Title
BRPI0817444A2 (pt) Prímeres de poliunucleotídeo
BRPI0818380A2 (pt) Combinação de herbicida-protetor
BRPI0815042A2 (pt) Compostos de pirazol
EP2131650A4 (en) PERFUSION REGULATION
EP2157090A4 (en) PYRAZINAMIDE COMPOUND
EP2162473A4 (en) MULTIFUNCTIONAL PRIMER
EP2233838A4 (en) COOKER
DE602008002772D1 (de) Polyvinylpyrrolidonpulverzusammensetzungen
EP2160187A4 (en) SPIROINDALONE
EP2197392A4 (en) Interspinous spacer
BRPI0814519A2 (pt) Organopolissiloxano
EP2211752A4 (en) biopulp
BRPI0812840A2 (pt) 2-imidazolinas
EP2237903A4 (en) METAL BENDING APPARATUS
EP2145884A4 (en) INDOLEDIONE DERIVATIVE
PT2792662T (pt) Compostos de morfinano
FI20075250A0 (fi) Ruokintalaitteisto
FI20075057A0 (fi) Mäntähydraulimoottori
DE502008003063D1 (de) Magnetventilinjektor
EP2128006A4 (en) DRIVING TYPE VEHICLE IN CALIFOURCHON
FI20075144A0 (fi) Intubaatioapuväline
EP2209817A4 (en) ANTIVIRAL COMPOSITIONS
FI20075115A0 (fi) Tuloilmayksikkö
NO20075340L (no) Sikkerhetsskjot
FI20075119A0 (fi) Työalustajärjestelmä

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: QIAGEN MANCHESTER LTD. (GB)

B25G Requested change of headquarter approved

Owner name: QIAGEN MANCHESTER LTD. (GB)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time